• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Statins may reduce mortality following diagnosis of colorectal cancer

byMonica ParksandDavid Wang
August 12, 2014
in Cardiology, Chronic Disease, Gastroenterology, Oncology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Statin use following diagnosis of colorectal cancer was associated with dose-dependent reductions in cancer-specific and all-cause mortality.           

Evidence Rating Level: 2 (Good) 

Study Rundown: Though primarily used in the management of hyperlipidemia and coronary heart disease, preclinical evidence has suggested that statins may play a role as adjuvant cancer therapy. Previous studies have demonstrated reduced mortality among colorectal cancer patients taking statins in a small cohort. The purpose of this study was to evaluate the relationship between statins and cancer-specific and all-cause mortality in over 7,500 patients diagnosed with colorectal cancer in the United Kingdom from 1998 to 2009. At the conclusion of this study, the authors found that statin use after diagnosis of colorectal cancer was associated with a 28% reduction in cancer-specific mortality in a dose-dependent relationship. Furthermore, statin use was also associated with reduced all-cause mortality. These results benefit from the large sample size with extended follow-up. However, potential confounders such as medication non-adherence and healthy user effects should be noted.

Click to read the study in JCO

Relevant Reading: Effect of statin therapy on colorectal cancer

In-Depth [retrospective cohort]: A total of 7,657 patients newly diagnosed with stage I-III colorectal cancer were identified from the National Cancer Data Repository (NCDR), United Kingdom Clinical Practice Research Datalink (CPRD) and the Office of National Statistics (ONS). Patients were excluded for previous NCDR cancer diagnoses, stage IV disease, or if they died in the first year following diagnosis. Average follow-up after diagnosis was 5 years. Compared to non-statin users, statin users had similar stage and grade of cancer but were more likely to be male, be older, to have a higher BMI, to have smoked, to have other comorbidities, and to use other medications. Overall, statin users had 28% reduction in rate of colorectal cancer-specific mortality compared to nonusers (HR 0.72; 95% CI, 0.64-0.81). A dose-dependent effect was observed as there was a 21% reduction in cancer-specific mortality among individuals with <1 year’s use and a 35% reduction in cancer-specific mortality among those with >1 year’s use. There was a 12% reduction in the rate of all-cause mortality in statin users (HR 0.88; 95% CI, 0.66 to 0.84).

More from this author: Rituximab linked with reduced chronic immune disease following stem cell transplantation, High-dose prophylaxis for hemophilia increases costs with minimal benefit, Ambrisentan found ineffective against idiopathic pulmonary fibrosis 

RELATED REPORTS

Moderate-intensity statin plus ezetimibe is non-inferior to high-intensity statin monotherapy

Systematic review and meta-analysis of statin-induced reduction in LDL-C demonstrates modest absolute benefits

Combination-drug therapy and earlier detection recommended to improve outcomes in heterozygous familial hypercholesterolemia

Image: PD 

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. 

Tags: Atorvastatincolon cancerstatins
Previous Post

Chest pain may be better than EKG, echo for predicting coronary artery disease prognosis

Next Post

Short course rifamycin matches isoniazid for treatment of tuberculosis

RelatedReports

2 Minute Medicine Rewind October 12 – 19, 2014
Cardiology

Moderate-intensity statin plus ezetimibe is non-inferior to high-intensity statin monotherapy

August 10, 2022
Implementation of pneumococcal vaccine programs linked to decreased antibiotic prescription
Cardiology

Systematic review and meta-analysis of statin-induced reduction in LDL-C demonstrates modest absolute benefits

April 7, 2022
2 Minute Medicine Rewind October 12 – 19, 2014
Cardiology

Combination-drug therapy and earlier detection recommended to improve outcomes in heterozygous familial hypercholesterolemia

November 16, 2021
Quick Take: The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomized trial
Cardiology

Statin therapy initiation is associated with diabetes progression

October 8, 2021
Next Post
Nationwide treatment regimen more than halves tuberculosis prevalence in China

Short course rifamycin matches isoniazid for treatment of tuberculosis

Mediterranean diet linked to reduced diabetes risk in high risk cardiovascular patients

Troponin use for suspected coronary syndrome limited in chronic kidney disease

Flexible sigmoidoscopy decreases colorectal cancer incidence and mortality

Flexible sigmoidoscopy decreases colorectal cancer incidence and mortality

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • LI-RADS outlines standards for liver imaging studies assessing HCC [Classics Series]
  • Daily disposable contact lenses may lower risk for Acanthamoeba keratitis
  • Vitamin D deficiency may be associated with sleep disorders in children
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.